24.00GBp0.00%Mkt Cap: 14.89M GBpP/E: InfinityLast update: 2026-05-13
RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufactu…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)Infinity
P/E (Forward)-60.00
PEG—
P/B2.09
P/S3.34
EV/EBITDA45.77
EV/Revenue2.79
EPS (TTM)0.00
EPS (Forward)-0.00
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF-1.33M GBp
CapEx (TTM)55.00K GBp
Net Debt/EBITDA-9.33
Net Debt-2.54M GBp
Technical
SMA 5016.63 (+44.4%)
SMA 20013.55 (+77.1%)
Beta0.97
S&P 52W Chg24.23%
Avg Vol (30d)336.37K
Avg Vol (10d)495.60K
Technical Indicators
RSI (14)83.4
MACD2.0018
MACD Signal1.6197
MACD Hist.+0.3821
BB Upper23.65 GBp
BB Middle19.09 GBp
BB Lower14.53 GBp
BB Width47.76%
ATR (14)1.284 GBp
Vol Ratio (20d)0.52x
52W Range
10.4293% of range25.00
52W High25.00 GBp
52W Low10.42 GBp
Profitability
Gross Margin81.06%
EBITDA Margin6.10%
Profit Margin-65.72%
Oper. Margin-26.46%
ROE-20.05%
ROA-17.63%
Revenue Growth85.30%
Earnings Growth—
Balance Sheet
Debt/Equity0.05
Current Ratio4.64
Quick Ratio3.62
Book Value/Sh0.1150 GBp
Cash/Share0.0570 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateSep 1, 2003
Ownership
Shares Out.62.06M
Float50.72M
Insiders50.62%
Institutions22.37%
Analyst Consensus
Rating—
Target (Mean)50.00 GBp
Target Range50.00 GBp – 50.00 GBp
# Analysts1
Company
Market Cap14.89M GBp
Enterprise Value12.45M GBp
Revenue (TTM)4.46M GBp
Gross Profit1.78M GBp
Net Income (TTM)-1.44M GBp
Revenue/Share0.0720 GBp
Fiscal Year EndSep 2025
MR QuarterMar 2025
Employees59
Last Price24.00 GBp
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—